3414 Peachtree Rd NE, Suite 725 Atlanta, GA, 30326
(404) 995-6671

Instagram X-twitter Linkedin

Menu

Home
News

NEWS

Headlines

All Posts
Carousel News
Financial News
Latest News
Market Opinion
Political News
Stock Analysis

Immuron Limited (NASDAQ: IMRN) Revenue Grew 179% While Working to Improve Immune-Related Diseases

Financial News, Latest News

Immuron Limited (NASDAQ: IMRN) Revenue Grew 179% While Working to Improve Immune-Related Diseases

September 20, 2024/

Immuron Limited (NASDAQ: IMRN) Revenue Grew 179% While Working to Improve Immune-Related Diseases Immuron Limited (NASDAQ: IMRN), an Australian biopharmaceutical…

All Posts
Stock Analysis
Latest News
Market Opinion
Political News
Financial News
Carousel News

ServisFirst Bancshares (NYSE:SFBS) Reports Strong Q1 2024 Growth and Expansion Plans

ServisFirst Bancshares (NYSE:SFBS) Reports Strong Q1 2024 Growth and Expansion Plans

April 22, 2024/

Salesforce Halts Informatica Acquisition Talks Over Terms Disagreement

Salesforce Halts Informatica Acquisition Talks Over Terms Disagreement

April 22, 2024/

Kinder Morgan Forecasts Surge in Natural Gas Demand by 2030 Amid AI Boom and Strategic Acquisitions

Kinder Morgan Forecasts Surge in Natural Gas Demand by 2030 Amid AI Boom and Strategic Acquisitions

April 17, 2024/

Rio Tinto Vows to Keep Resolution Mine Copper Within U.S. Borders amid Controversy

Rio Tinto Vows to Keep Resolution Mine Copper Within U.S. Borders amid Controversy

April 16, 2024/

Laser Photonics (LASE) Reports Impressive Revenue Surge in Q4 2023, Unveils Strategic Plans

Laser Photonics (LASE) Reports Impressive Revenue Surge in Q4 2023, Unveils Strategic Plans

April 15, 2024/

Salesforce in Advanced Talks to Acquire Informatica Amid Tech Sector Deal-Making Surge

Salesforce in Advanced Talks to Acquire Informatica Amid Tech Sector Deal-Making Surge

April 15, 2024/

Market Opinion

All Posts
Market Opinion

Job Growth Moderates Amidst Employer Caution and Worker Stability

December 8, 2023/

AI Showdown: Google Unveils Gemini to Challenge OpenAI’s GPT-4 as Amazon Fires Up its Arsenal to Rival Microsoft

December 7, 2023/

Wall Street Closes with Mixed Signals Amid Speculation of Fed Rate Cut Triggered by Employment Data

December 6, 2023/

Major Stocks Slide as Megacap Companies Relinquish Prior Advances

December 5, 2023/

Oil Prices Stable as Rate Cut Speculations and Middle East Risks Persist

December 4, 2023/

Banking on Change: TD Bank’s Fiscal Tightrope Walk

December 1, 2023/

ADVERTISEMENT

Newsletter

Subscription Form

Contact

Name

Email

Message

Stock Analysis

All Posts
Stock Analysis

CRA International, Inc. (CRAI)

CRA International, Inc. (CRAI)

June 1, 2023/

Sify Technologies Limited (SIFY)

Sify Technologies Limited (SIFY)

June 2, 2023/

Cambridge Bancorp (CATC)

Cambridge Bancorp (CATC)

June 2, 2023/

DXP Enterprises, Inc. (DXPE)

DXP Enterprises, Inc. (DXPE)

June 2, 2023/

Codorus Valley Bancorp, Inc. (CVLY)

Codorus Valley Bancorp, Inc. (CVLY)

June 2, 2023/

Rocky Brands, Inc. (RCKY)

June 4, 2023/

Computer Task Group, Incorporated (CTG)

Computer Task Group, Incorporated (CTG)

June 5, 2023/

Malvern Bancorp, Inc. (MLVF)

Malvern Bancorp, Inc. (MLVF)

June 5, 2023/

FONAR Corporation (FONR)

FONAR Corporation (FONR)

June 5, 2023/

News You May Like

All Posts
Stock Analysis
Latest News
Market Opinion
Political News
Financial News
Carousel News

Immuron Limited (NASDAQ: IMRN) Revenue Grew 179% While Working to Improve Immune-Related Diseases

Immuron Limited (NASDAQ: IMRN) Revenue Grew 179% While Working to Improve Immune-Related Diseases

Immuron Limited (NASDAQ: IMRN) Revenue Grew 179% While Working to Improve Immune-Related Diseases Immuron Limited (NASDAQ: IMRN), an Australian biopharmaceutical…

All Posts
Stock Analysis
Latest News
Market Opinion
Political News
Financial News
Carousel News

Raymond James Downgrades AMD to Outperform, Citing Elevated AI Revenue Expectations; Adjusts Price Target to $195

Raymond James Downgrades AMD to Outperform, Citing Elevated AI Revenue Expectations; Adjusts Price Target to $195

January 31, 2024/

Ancora Holdings-Led Investor Group Targets CEO Ouster with $1 Billion Stake in Norfolk Southern

Ancora Holdings-Led Investor Group Targets CEO Ouster with $1 Billion Stake in Norfolk Southern

January 31, 2024/

Hanover Insurance (THG) Posts Strong Q4 2023, Eyes Growth in 2024

Hanover Insurance (THG) Posts Strong Q4 2023, Eyes Growth in 2024

February 1, 2024/

Goldman Sachs Boosts Nvidia’s Target Price to $800, Citing Strong AI Demand and Improved GPU Supply

Goldman Sachs Boosts Nvidia’s Target Price to $800, Citing Strong AI Demand and Improved GPU Supply

February 5, 2024/

Triumph Group Lands Five-Year MRO Contract for Boeing Aircraft Nacelles

Triumph Group Lands Five-Year MRO Contract for Boeing Aircraft Nacelles

February 6, 2024/

JELD-WEN Revamps Senior Leadership Team to Drive Operational Excellence and Customer Value

JELD-WEN Revamps Senior Leadership Team to Drive Operational Excellence and Customer Value

February 7, 2024/

The Barbey Family, Descendants of VF Corp Founder, Back Activist Investor Engaged Capital for Board Seats

The Barbey Family, Descendants of VF Corp Founder, Back Activist Investor Engaged Capital for Board Seats

February 12, 2024/

North Carolina Upgrades Financial Management with Oracle Cloud ERP

North Carolina Upgrades Financial Management with Oracle Cloud ERP

February 12, 2024/

Brighthouse Financial (NASDAQ:BHF) Ends 2023 Strong, Announces $250M Stock Buyback and Surpasses Annuity Sales Targets

Brighthouse Financial (NASDAQ:BHF) Ends 2023 Strong, Announces $250M Stock Buyback and Surpasses Annuity Sales Targets

February 13, 2024/

Bridgewater Associates Bolsters Investment in Nvidia, Expands Portfolio in High-Growth Tech Stocks

February 14, 2024/

Agios Pharmaceuticals Reports Positive Clinical Updates and Strong Financial Position, Poised for Therapeutic Advancements

Agios Pharmaceuticals Reports Positive Clinical Updates and Strong Financial Position, Poised for Therapeutic Advancements

February 16, 2024/

Fmr LLC Boosts Molina Healthcare Stake as Institutional Investors Eye Potential Mega Merger

February 19, 2024/

Western Midstream Partners Clarifies No Sales Process Initiated Amid Speculation

Western Midstream Partners Clarifies No Sales Process Initiated Amid Speculation

February 20, 2024/

Medical Properties Trust Advances $2 Billion Liquidity Plan

Medical Properties Trust Advances $2 Billion Liquidity Plan

February 21, 2024/

Elevation Oncology Initiates Phase 1 Trial Expansion for Promising Cancer Therapy EO-3021 in Japan

Elevation Oncology Initiates Phase 1 Trial Expansion for Promising Cancer Therapy EO-3021 in Japan

February 22, 2024/

Fresh Del Monte Produce Faces Revenue Decline in Latest Quarter, Analysts Remain Cautious

Fresh Del Monte Produce Faces Revenue Decline in Latest Quarter, Analysts Remain Cautious

February 25, 2024/

The FDA Grants Priority Review for Potential New Follicular Lymphoma Treatment, Epcoritamab, by Genmab A/S and AbbVie

The FDA Grants Priority Review for Potential New Follicular Lymphoma Treatment, Epcoritamab, by Genmab A/S and AbbVie

February 26, 2024/

Aaron’s Inc. Reports Robust E-commerce Growth and Financial Efficiency Measures Amidst Segment Challenges

Aaron’s Inc. Reports Robust E-commerce Growth and Financial Efficiency Measures Amidst Segment Challenges

February 27, 2024/

Viking Therapeutics Raises $550 Million in Public Offering to Fuel Biopharmaceutical Innovation

Viking Therapeutics Raises $550 Million in Public Offering to Fuel Biopharmaceutical Innovation

February 28, 2024/

Kinetik (NYSE: KNTK) Reports Stellar Financial Year, Projects Strong Growth for 202

Kinetik (NYSE: KNTK) Reports Stellar Financial Year, Projects Strong Growth for 202

February 29, 2024/

Arkhouse and Brigade Up the Ante: Increase Bid for Macy’s in Pursuit of Acquisition

Arkhouse and Brigade Up the Ante: Increase Bid for Macy’s in Pursuit of Acquisition

March 3, 2024/

Chubb Limited Announces $1 Billion Senior Notes Offering to Bolster Corporate Funds

Chubb Limited Announces $1 Billion Senior Notes Offering to Bolster Corporate Funds

March 4, 2024/

Ionis Pharmaceuticals Receives Price Target Increase from Oppenheimer Amid Positive Growth Outlook

March 6, 2024/

Oppenheimer Boosts CrowdStrike Price Target to $355, Upbeat on Company’s Growth Outlook

Oppenheimer Boosts CrowdStrike Price Target to $355, Upbeat on Company’s Growth Outlook

March 6, 2024/

AI Chip Revenue Projections Send Broadcom Stock on Rollercoaster Ride

AI Chip Revenue Projections Send Broadcom Stock on Rollercoaster Ride

March 7, 2024/

Reddit Plans IPO, Aiming for Valuation of Over $7 Billion

Reddit Plans IPO, Aiming for Valuation of Over $7 Billion

March 10, 2024/

Rosenblatt Forecasts Qualcomm’s Snapdragon as Key Player in AI-Focused Computing Platforms

Rosenblatt Forecasts Qualcomm’s Snapdragon as Key Player in AI-Focused Computing Platforms

March 11, 2024/

FEC Clears NextEra Energy’s FPL of Campaign Finance Violations Following Review

FEC Clears NextEra Energy’s FPL of Campaign Finance Violations Following Review

March 12, 2024/

Singtel Shares Dip Over 1% Amid Reports of Advanced Talks for Optus Stake Sale

Singtel Shares Dip Over 1% Amid Reports of Advanced Talks for Optus Stake Sale

March 13, 2024/

Foxconn Surges on Strong Q4 Earnings and Bullish AI Demand Outlook

Foxconn Surges on Strong Q4 Earnings and Bullish AI Demand Outlook

March 15, 2024/

End of Content.

All News

The current query has no posts. Please make sure you have published items matching your query.

Instagram Linkedin X-twitter

Quick Links

Menu

Home
News 1
Contact Us

Get In Touch

3414 Peachtree RdNE, Suite 725 Atlanta, GA, 30326
Office 205 E 42nd St Suite 1900, New, NY 10017
(404) 995-6671

JOIN OUR NEWSLETTER

Thank you for Signing Up

Please correct the marked field(s) below.

1,true,6,Contact Email,2 1,false,1,First Name,2 1,false,1,Last Name,2

© 2024 Copyright Landon capital Terms and Conditions | Privacy Policy

Retail Investor Support

Equity Research Coverage

Public Relations